Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Shapiro

Showing results (1031-1040 of 1,181) with videos related to

Pageof 119
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura, Ilana Belitskaya-Lévy, Amy E Rose, et al.
Breast Cancer Research and Treatment|January 8, 2010
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancerAlejandra T Perez, Banu Arun, Debu Tripathy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2017
Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in BotswanaMaryanne Ibrahim, Sikhulile Moyo, Terence Mohammed, et al.
Infection and Immunity|March 10, 2026
The <i>Borreliella burgdorferi</i> BosR-associated small non-coding RNA BasA regulates virulenceBrittany L Shapiro, Prashant Jaiswal, Lisa J Funkhouser-Jones, et al.
The Lancet. Global Health|May 13, 2022
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in BotswanaEllen C Caniglia, Rebecca Zash, Sonja A Swanson, et al.
Molecular Cancer Therapeutics|November 6, 2009
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignanciesTanios S Bekaii-Saab, Julie M Roda, Kristan D Guenterberg, et al.
Palliative Medicine|October 9, 2010
A 2-week prognostic prediction model for terminal cancer patients in a palliative care unit at a Japanese general hospitalSachiko Ohde, Akitoshi Hayashi, Osamu Takahasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research ProgramNaomi Y Ko, Julie S Darnell, Elizabeth Calhoun, et al.
Plos One|February 8, 2014
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic optionsPierluigi Gasparini, Matteo Fassan, Luciano Cascione, et al.
Pigment Cell & Melanoma Research|October 2, 2010
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose, Guimin Wang, Douglas Hanniford, et al.
Pageof 119

Showing results (1031-1040 of 1,181) with videos related to

Sort By:
Pageof 119
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura, Ilana Belitskaya-Lévy, Amy E Rose, et al.
Breast Cancer Research and Treatment|January 8, 2010
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancerAlejandra T Perez, Banu Arun, Debu Tripathy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2017
Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in BotswanaMaryanne Ibrahim, Sikhulile Moyo, Terence Mohammed, et al.
Infection and Immunity|March 10, 2026
The <i>Borreliella burgdorferi</i> BosR-associated small non-coding RNA BasA regulates virulenceBrittany L Shapiro, Prashant Jaiswal, Lisa J Funkhouser-Jones, et al.
The Lancet. Global Health|May 13, 2022
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in BotswanaEllen C Caniglia, Rebecca Zash, Sonja A Swanson, et al.
Molecular Cancer Therapeutics|November 6, 2009
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignanciesTanios S Bekaii-Saab, Julie M Roda, Kristan D Guenterberg, et al.
Palliative Medicine|October 9, 2010
A 2-week prognostic prediction model for terminal cancer patients in a palliative care unit at a Japanese general hospitalSachiko Ohde, Akitoshi Hayashi, Osamu Takahasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research ProgramNaomi Y Ko, Julie S Darnell, Elizabeth Calhoun, et al.
Plos One|February 8, 2014
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic optionsPierluigi Gasparini, Matteo Fassan, Luciano Cascione, et al.
Pigment Cell & Melanoma Research|October 2, 2010
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose, Guimin Wang, Douglas Hanniford, et al.
Pageof 119